IL-15 immunotherapy is a viable strategy for COVID-19

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
IL-15 immunotherapy is a viable strategy for COVID-19
Authors
Keywords
COVID-19, SARS-CoV-2, Pulmonary inflammation, Cytokine storm, Immune cells, Interleukin-15
Journal
CYTOKINE & GROWTH FACTOR REVIEWS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-06-06
DOI
10.1016/j.cytogfr.2020.06.008

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.